Vanguard Group Inc. Increases Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Vanguard Group Inc. increased its position in Pediatrix Medical Group, Inc. (NYSE:MDFree Report) by 0.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,393,239 shares of the company’s stock after purchasing an additional 23,115 shares during the quarter. Vanguard Group Inc. owned 12.36% of Pediatrix Medical Group worth $96,657,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. SummerHaven Investment Management LLC boosted its stake in Pediatrix Medical Group by 2.3% during the 4th quarter. SummerHaven Investment Management LLC now owns 52,900 shares of the company’s stock valued at $492,000 after acquiring an additional 1,208 shares during the last quarter. Performa Ltd US LLC boosted its stake in Pediatrix Medical Group by 130.8% during the 4th quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock valued at $28,000 after acquiring an additional 1,700 shares during the last quarter. M&T Bank Corp boosted its stake in Pediatrix Medical Group by 6.9% during the 4th quarter. M&T Bank Corp now owns 48,771 shares of the company’s stock valued at $453,000 after acquiring an additional 3,157 shares during the last quarter. Counterpoint Mutual Funds LLC boosted its stake in Pediatrix Medical Group by 53.4% during the 4th quarter. Counterpoint Mutual Funds LLC now owns 10,140 shares of the company’s stock valued at $94,000 after acquiring an additional 3,528 shares during the last quarter. Finally, Moody National Bank Trust Division boosted its stake in Pediatrix Medical Group by 23.4% during the 4th quarter. Moody National Bank Trust Division now owns 41,573 shares of the company’s stock valued at $387,000 after acquiring an additional 7,871 shares during the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Down 4.1 %

Shares of NYSE:MD opened at $6.81 on Monday. The stock has a market capitalization of $573.06 million, a price-to-earnings ratio of -8.01, a price-to-earnings-growth ratio of 1.35 and a beta of 1.56. Pediatrix Medical Group, Inc. has a 1-year low of $6.70 and a 1-year high of $15.02. The company’s fifty day moving average is $7.73 and its two-hundred day moving average is $8.76. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.72 and a current ratio of 1.72.

Pediatrix Medical Group (NYSE:MDGet Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.02. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The business had revenue of $495.10 million for the quarter, compared to analysts’ expectations of $496.25 million. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.13 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on MD shares. Deutsche Bank Aktiengesellschaft upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 price objective on the stock in a research note on Friday, June 7th. StockNews.com downgraded shares of Pediatrix Medical Group from a “hold” rating to a “sell” rating in a research note on Monday, June 24th. Finally, Truist Financial reissued a “hold” rating and set a $10.00 target price on shares of Pediatrix Medical Group in a report on Wednesday, May 15th. One equities research analyst has rated the stock with a sell rating and five have given a hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $9.10.

Read Our Latest Report on MD

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Articles

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MDFree Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.